We assessed the prevalence of microalbuminuria (MAU) and the relationships with other cardiovascular (CV) risk factors among a middle-aged Chinese population. Data from 10 313 participants were included in our cross-sectional survey. Microalbuminuria was defined as the urine albumin to creatinine ratio of 30:300 mg/g from a single-spot morning urine sample. Microalbuminuria was found to be common in males and females (15.04% vs 10.09%) aged 35 to 64 years in this Chinese general population, especially in those with obesity, hypertension, and diabetes. Multivariate analysis found that body mass index, triglyceride, high-sensitivity C-reactive protein, alcohol consumption, hypertension, and diabetes were independently associated with MAU. Microalbuminuria may be a useful indicator for risk of CV disease in general populations.
NugentRAFathimaSFFeiglABChyungD. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118(3):c269–c277.
2.
ReddyKSYusufS. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97(6):596–601.
3.
BeagleholeRYachD. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet. 2003;362(9387):903–908.
4.
BelloAKNwankwoEEl NahasAM. Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl. 2005;(98):S11–S17.
5.
MogensenCE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int. 1987;31(2):673–689.
6.
SabanayagamCShankarA. Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease. Clin Exp Nephrol. 2011;15(1):92–99.
7.
ChenBYangDChenYXuWYeBNiZ. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin Chim Acta. 2010;411(9-10):705–709.
8.
GuoLChengYWangX. Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol. 2012;49(suppl 1):S65–S71.
9.
OzyolAYucelOEgeMRZorluAYilmazMB. Microalbuminuria is associated with the severity of coronary artery disease independently of other cardiovascular risk factors. Angiology. 2012;63(6):457–460.
10.
BohmMThoenesMDanchinNBramlagePLa PuertaPVolpeM. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study. J Hypertens. 2007;25(11):2317–2324.
11.
MeisingerCHeierMLandgrafRHappichMWichmannHEPiehlmeierW. Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study. BMC Health Serv Res. 2008;8:226.
12.
DonnellyRYeungJMManningG. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. J Hypertens Suppl. 2003;21(1):S7–S12.
13.
HillegeHL. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106(14):1777–1782.
14.
GersteinHCMannJFYiQ. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421–426.
15.
HillegeHLJanssenWMBakAA. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249(6):519–526.
16.
LioudakiEFlorentinMGanotakisESMikhailidisDP. Microalbuminuria: a neglected cardiovascular risk factor in non-diabetic individuals?Curr Pharm Des. 2013;19(27):4964–4980.
17.
FolsomAR. Classical and novel biomarkers for cardiovascular risk prediction in the United States. J Epidemiol. 2013;23(3):158–162.
18.
WinocourPHHarlandJOMillarJPLakerMFAlbertiKG. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis. 1992;93(1-2):71–81.
19.
BarzilayJIPetersonDCushmanM. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. Am J Kidney Dis. 2004;44(1):25–34.
20.
ShengCSHuBCFanWXZouJLiYWangJG. Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population. Diabetol Metab Syndr. 2011;3(1):6.
21.
LinCCLiuCSLiTCChenCCLiCILinWY. Microalbuminuria and the metabolic syndrome and its components in the Chinese population. Eur J Clin Invest. 2007;37(10):783–790.
22.
ZhangLWangFWangL. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822.
23.
MauMKWestMRSharaNM. Epidemiologic and clinical factors associated with chronic kidney disease among Asian Americans and Native Hawaiians. Ethn Health. 2007;12(2):111–127.
24.
ZhangLFYangJHongZ. Proportion of different subtypes of stroke in China. Stroke. 2003;34(9):2091–2096.
25.
ZhouBFZhangHYWuYF. Ecological analysis of the association between incidence and risk factors of coronary heart disease and stroke in Chinese populations. CVD Prevent. 1998;1(3):207–216.
26.
ZhouB. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23(1):5–10.
27.
PruijmMTMadeleineGRiesenWFBurnierMBovetP. Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers. J Hypertens. 2008;26(5):871–877.
28.
KontaTHaoZAbikoH. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 2006;70(4):751–756.
29.
TebbeUBramlagePThoenesM. Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-Search survey. Swiss Med Wkly. 2009;139(33-34):473–480.
30.
ChowtaNKPantPChowtaMN. Microalbuminuria in diabetes mellitus: association with age, sex, weight, and creatinine clearance. Indian J Nephrol. 2009;19(2):53–56.
31.
JonesCAFrancisMEEberhardtMS. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002;39(3):445–459.
32.
YuyunMFKhawK-TLubenR. Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: the EPIC-Norfolk population-based study. Eur J Cardiovasc Prev Rehabil. 2004;11(3):207–213.
33.
JafarTHQadriZHashmiS. Prevalence of microalbuminuria and associated electrocardiographic abnormalities in an Indo-Asian population. Nephrol Dial Transplant. 2009;24(7):2111–2116.
34.
OgunniyiMOCroftJBGreenlundKJGilesWHMensahGA. Racial/ethnic differences in microalbuminuria among adults with prehypertension and hypertension: national health and nutrition examination survey (NHANES), 1999-2006. Am J Hypertens. 2010;23(8):859–864.
35.
UssaiKEKeithSWPequignotEFalknerB. Risk factors associated with urinary albumin excretion in African Americans. J Hum Hypertens. 2011;25(1):3–10.
36.
ChenJMuntnerPHammLL. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140(3):167–174.
ThoenesMReilJCKhanBV. Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag. 2009;5(4):577–585.
39.
CoonrodBAEllisDBeckerDJ. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh epidemiology of diabetes complications study. Diabetes Care. 1993;16(10):1376–1383.
40.
BonnetFMarreMHalimiJM. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens. 2006;24(6):1157–1163.
41.
LurbeETorroMIAlvarezJAguilarFFernandez-FormosoJARedonJ. Prevalence and factors related to urinary albumin excretion in obese youths. J Hypertens. 2013;31(11):2230–2236.
42.
SchmiedelOSchroeterMLHarveyJN. Microalbuminuria in Type 2 diabetes indicates impaired microvascular vasomotion and perfusion. Am J Physiol Heart Circ Physiol. 2007;293(6):H3424–H3431.
